Randomised controlled trials for COVID-19: evaluation of optimal randomisation methodologies—need for data validation of the completed trials and to improve ongoing and future randomised trial designs

During the emerging COVID-19 (coronavirus disease 2019) pandemic, initially there were no proven treatment options. With the release of randomised controlled trial (RCT) results, we are beginning to see possible treatment options for COVID-19. The RECOVERY trial showed an absolute risk reduction in...

Descripción completa

Detalles Bibliográficos
Autores principales: Emani, Venkata R., Goswami, Sanjeev, Nandanoor, Dheeraj, Emani, Shaila R., Reddy, Nidhi K., Reddy, Raghunath
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by Elsevier Ltd. 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7659806/
https://www.ncbi.nlm.nih.gov/pubmed/33189891
http://dx.doi.org/10.1016/j.ijantimicag.2020.106222

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7659806/
https://www.ncbi.nlm.nih.gov/pubmed/33189891
http://dx.doi.org/10.1016/j.ijantimicag.2020.106222

Ejemplares similares